Bando Tomoyuki, Fujita Setsuko, Nagano Naoko, Yoshikawa Soichiro, Yamanishi Yoshinori, Minami Masashi, Karasuyama Hajime
Department of Immune Regulation, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Ono pharmaceutical co., ltd. Exploratory Research Laboratories, 3-1-1 Sakurai, Shimamoto-Cho, Mishima-Gun, Osaka 618-8585, Japan.
Biochem Biophys Rep. 2017 Mar 15;10:82-87. doi: 10.1016/j.bbrep.2017.03.004. eCollection 2017 Jul.
Basophils have been erroneously considered as minor relatives of mast cells, due to some phenotypic similarity between them. While recent studies have revealed non-redundant roles for basophils in various immune responses, basophil-derived effector molecules, including lipid mediators, remain poorly characterized, compared to mast cell-derived ones. Here we analyzed and compared eicosanoids produced by mouse basophils and mast cells when stimulated with IgE plus allergens. The production of 5-LOX metabolites such as LTB4 and 5-HETE was detected as early as 0.5 h post-stimulation in both cell types, even though their amounts were much smaller in basophils than in mast cells. In contrast, basophils and mast cells showed distinct time course in the production of COX metabolites, including PGD2, PGE2 and 11-HETE. Their production by mast cells was detected at both 0.5 and 6 h post-stimulation while that by basophils was detectable only at 6 h. Of note, mast cells showed 8-9 times higher levels of COX-1 than did basophils at the resting status. In contrast to unaltered COX-1 expression with or without stimulation, COX-2 expression was up-regulated in both cell types upon activation. Importantly, when activated, basophils expressed 4-5 times higher levels of COX-2 than did mast cells. In accordance with these findings, the late-phase production of the COX metabolites by basophils was completely ablated by COX-2 inhibitor whereas the early-phase production by mast cells was blocked by COX-1 but not COX-2 inhibitor. Thus, the production of COX metabolites is differentially regulated by COX-1 and COX-2 in basophils and mast cells.
由于嗜碱性粒细胞和肥大细胞之间存在一些表型相似性,它们曾被错误地认为是肥大细胞的次要亲属。虽然最近的研究揭示了嗜碱性粒细胞在各种免疫反应中具有不可替代的作用,但与肥大细胞衍生的效应分子相比,包括脂质介质在内的嗜碱性粒细胞衍生的效应分子的特征仍知之甚少。在这里,我们分析并比较了用IgE加过敏原刺激时小鼠嗜碱性粒细胞和肥大细胞产生的类花生酸。在两种细胞类型中,早在刺激后0.5小时就检测到了5-LOX代谢产物如LTB4和5-HETE的产生,尽管嗜碱性粒细胞中的含量比肥大细胞中的要少得多。相比之下,嗜碱性粒细胞和肥大细胞在COX代谢产物(包括PGD2、PGE2和11-HETE)的产生上表现出不同的时间进程。肥大细胞在刺激后0.5小时和6小时都检测到了它们的产生,而嗜碱性粒细胞仅在6小时可检测到。值得注意的是,在静息状态下,肥大细胞的COX-1水平比嗜碱性粒细胞高8-9倍。与刺激与否时COX-1表达不变相反,两种细胞类型在激活后COX-2表达均上调。重要的是,激活时,嗜碱性粒细胞表达的COX-2水平比肥大细胞高4-5倍。根据这些发现,COX-2抑制剂完全消除了嗜碱性粒细胞COX代谢产物的晚期产生,而肥大细胞的早期产生被COX-1抑制剂而非COX-2抑制剂阻断。因此,嗜碱性粒细胞和肥大细胞中COX代谢产物的产生受COX-1和COX-2的差异调节。